Anti-CYP2A13 antibody - C-terminal (ab135703) at 1/50 dilution + MDA-MB231 cell lysate at 35 µg
Immunohistochemical analysis of Formalin-fixed, paraffin-embedded Human breast carcinoma tissue labelling CYP2A13 with ab135703 at 1/50 dilution followed by peroxidase-conjugated secondary antibody and DAB staining.
Flow cytometric analysis of MDA-MB231 cells staining CYP2A13 with ab135703 at 1/10 dilution (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.